Jan 29 (Reuters) - SYNTHETICMR AB (PUBL):
* SEGMENTATION AND QUANTIFICATION OF BRAIN TISSUE, AND INDUSTRY FIRST MYELIN VOLUME MEASUREMENTS IN SYMRI NOW FDA CLEARED‍​
* SYNTHETICMR AB (PUBL) - SAYS ‍SYMRI AS A WHOLE CAN NOW BE OFFERED TO CLINICS AND HOSPITALS ON US MARKET. Source text for Eikon: Further company coverage: (Gdynia Newsroom)
 